Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • threads
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Safety
    • Nurse Well-Being
    • Drug Reference Sheets
    • ONS Congress
    • Specific Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Get Involved
    Stories View All
    View All
    cozy hospital room with bed and computer
    Interprofessional Issues
    Novel, Interprofessional Approach Enhances Bed Assignments for Individuals on Antineoplastic Drugs in a Hospital Setting
    August 22, 2024
    hand touching futuristic screen that represents artificial intelligence
    Nurse Empowerment
    How AI Can Support Oncology Nurses’ Spirit of Inquiry
    August 15, 2024
    person with brown clothes holding patient's hand in support on hospital bed
    Nurse Empowerment
    Sharing Our Stories Supports, Celebrates, and Advances the Nursing Profession
    July 04, 2024
    publish with ONS Voice
    Nursing Professional Development
    Publish Your First Article With ONS Voice
    March 19, 2024
    A family of nurses
    Nurse Well-Being
    When Health Care Is Woven in Our Family Fabric, We Find Support in Unexpected Places
    March 07, 2024
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home
    • Advocacy

    Test Advocacy Headlines Article 3

    January 12, 2017 by Admin
    Share
    • Share on Twitter
    • Share on Facebook
    • Share on Pinterest
    • Share on LinkedIn
    • Email Article
    • Print Article
    • Adverse Events

    To discuss the information in this article with other oncology nurses, visit the ONS Communities.

    To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

    Related Content

    For Oxaliplatin Hypersensitivity Reactions, Prevention Is the Best Strategy, but Here’s How to Manage Them
    Adverse Events
    For Oxaliplatin Hypersensitivity Reactions, Prevention Is the Best Strategy, but Here’s How to Manage Them
    April 09, 2019
    Manage Immune-Related Adverse Events in Patients on Durvalumab
    Adverse Events
    Manage Immune-Related Adverse Events in Patients on Durvalumab
    August 11, 2020
    ONS Congress
    Palonosetron HCL Is a Preferred Treatment for Moderately Emetogenic Chemotherapies
    July 02, 2017
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Contact Us
  • Advertising
  • Newsroom
  • Conferences
  • RSS Feed
  • Sitemap
  • Legal Notices

    • Subscribe to ONS Voice Updates

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • threads
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2024 Oncology Nursing Society
    Back to Top ▲